Published in Cancer Weekly, April 24th, 2006
"The objective of this study was to evaluate the ability of FDG-PET to predict the response of primary tumor and nodal disease to preoperative induction chemoradiotherapy in patients with NSCLC. FDG-PET studies were performed before and after completion of chemoradiotherapy prior to surgery in 26 patients with NSCLC. FDG-PET imaging was performed at 1 h (early) and 2 h (delayed) after injection," investigators in Japan reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.